Search results
Kim Kardashian’s Met Gala Look Had 1 Detail So Extreme It Made People Uncomfortable
HuffPost· 5 days agoKim Kardashian courted controversy at Monday’s Met Gala due to a very uncomfortable-looking aspect...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
WKRN Nashville· 3 days agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 2 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infections
United Press International via Yahoo News· 3 days agoAntibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S....
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days ago“Our top priority is executing on our strategy to accelerate the development and delivery of transformative medicines for patients, and we are confident that we can accomplish this mission while ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Natixis Advisors L.P.
ETF DAILY NEWS· 5 days agoNatixis Advisors L.P. decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The ...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 5 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis
Medscape· 3 days agoNSAIDs, the primary pain management therapy for AS, increased the risk for vascular events and...
Nichols & Pratt Advisers LLP MA Has $80.12 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 14 hours agoNichols & Pratt Advisers LLP MA cut its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & ...
Catalyst Financial Partners LLC Trims Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 13 hours agoCatalyst Financial Partners LLC reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 11.6% in the 4th quarter, according to its most recent 13F filing with the Securities ...